Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...
Mid-Day

Stem Cell Leukemia Conditions and Indications: When Stem Cell Therapy Becomes a Critical Option

At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...
Medical Xpress

Stem cell infusion timing can prevent acute graft-versus-host disease

A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation ...
The Scientist

Bone Marrow Banking Boosts Life-Saving Cell Therapy Development

Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver ...
Hosted on MSN

Life-saving stem cell centre welcomes first donors

The UK's first stem cell collection centre strictly dedicated to transplants has started welcoming donors. The Anthony Nolan Cell Collection Centre, based at Nottingham's Queen's Medical Centre (QMC), ...